Sonoma Pharmaceuticals
SNOA
15 hedge funds and large institutions have $473K invested in Sonoma Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
25% more funds holding
Funds holding: 12 → 15 (+3)
46% less capital invested
Capital invested by funds: $870K → $473K (-$397K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$73.2K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$34.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.67K |
| 4 |
JFGIW
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
|
+$3.12K |
| 5 |
Morgan Stanley
New York
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$28K |
SNOA Hedge Fund Activity: Q4 2014 in Review
15 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2014, worth a combined $473K — down 46% from $870K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SNOA positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Wealth Advisors, adding an estimated $73.2K. The largest seller was Jane Street, exiting entirely with an estimated $28K sold.
- 15 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2014, up from 12 in Q3 2014.
- Funds reported $473K of Sonoma Pharmaceuticals stock for Q4 2014, down 46% quarter-over-quarter.
- 5 funds opened new Sonoma Pharmaceuticals positions in Q4 2014 and 1 closed out, a net change of +4 holders.
- The largest Sonoma Pharmaceuticals buyer in Q4 2014 was B. Riley Wealth Advisors, an estimated $73.2K added.
- The largest Sonoma Pharmaceuticals seller in Q4 2014 was Jane Street, an estimated $28K sold.
Based on aggregated 13F filings for Q4 2014.